« Return to News | Study Conduct

NIHR Clinical Research Network studies hit record high

Tuesday, May 31, 2011 03:32 PM

The number of commercial studies adopted into the National Institute for Health Research’s Clinical Research Network (NIHR CRN) Portfolio in England during the third quarter of 2010-2011 reached 115, the highest level since the network started compiling quarterly reports in 2008, according to PharmaTimes.

The commercial study tally for October to December 2010 (the NIHR’s financial year runs from April 1 to March 31) was 125% more than in the same period in 2009-2010, reflecting progress made by the network in engaging with the clinical research community, the NIHR CRN said.

According to the network, two core factors were behind the upturn: more chief investigators insisting studies should go through the NIHR CRN and more awareness in the life sciences industry of available network services, such as a range of investigators and research sites throughout England, standard templates to speed costing and contract negotiations and study feasibility advice from key opinion leaders. 


Lucy Pollock, marketing manager for clinical studies at Medtronic, also cited the benefits of network studies for the overall research infrastructure. “The Clinical Research Network ensures your study receives appropriate resources, but it also promotes a positive cycle of research,” she said.  “This means the funding we feed into the NHS is channeled back into research and helps strengthen research capacity.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.